Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,977,175
-$21,333 QoQ
Shares Held
5,460
-3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#1,285
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. AMGN ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,613 | $4,219,203 | |
| 2 | AMGN |
Amgen Inc
This page
|
5,460 | $1,977,175 | |
| 3 | NVO |
Novo Nordisk A S
|
33,268 | $1,594,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,116 | $1,556,906 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,198 | $875,708 | |
| 6 | ABBV |
AbbVie Inc.
|
3,016 | $758,946 | |
| 7 | LLY |
ELI LILLY & Co
|
345 | $413,803 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,994 | $251,921 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,977,175 | 5,460 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,998,508 | 5,680 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,875,486 | 5,730 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,644,661 | 5,828 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,657,390 | 5,936 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,930,363 | 6,196 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,694,941 | 6,503 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,095,331 | 6,503 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,034,986 | 6,513 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,992,514 | 7,008 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,018,444 | 7,008 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,910,346 | 7,108 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,567,461 | 7,060 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,715,216 | 7,095 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,879,189 | 7,155 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,637,531 | 7,265 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,762,708 | 7,245 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,751,985 | 7,245 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,629,907 | 7,245 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,540,649 | 7,245 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,765,968 | 7,245 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,803,872 | 7,250 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,666,920 | 7,250 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,842,660 | 7,250 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,709,985 | 7,250 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,527,570 | 7,535 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||